Omeros Corporation ( OMER) - Stock Earnings
OMER Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
OMER Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 86.5 million USD | — USD |
| 2026Q1 | 56.1 million USD | 9.9 million USD |
| 2026Q2 | 13.2 million USD | 28.5 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
OMER Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -117.8 million USD | — USD |
| 2024 | -156.8 million USD | — USD |
| 2025 | -3.4 million USD | — USD |
| 2026 Est. | — | — |
OMER
Price: $18.79
Earnings Per Share: 1.65 USD
P/E Ratio: 10.42
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 328300
Ebitda: -4.6 millionMarket Capitalization: 1.3 billion